| CASE REPORT |
|
| Year : 2022 | Volume
: 2
| Issue : 3 | Page : 714-715 |
|
|
Herpes zoster masquerading viral endophthalmitis after ozurdex intravitreal implant
Abhinav Dhami1, Nimrata Bajaj Dhami2, Gobinder Singh3
1 Retina and Cataract Services, Dhami Eye Care Hospital, Ludhiana, Punjab, India
2 Cornea, Cataract and Refractive Clinic, Dhami Eye Care Hospital, Ludhiana, Punjab, India
3 Cataract and Refractive Clinic, Dhami Eye Care Hospital, Ludhiana, Punjab, India
Correspondence Address:
Dr. Abhinav Dhami
Dhami Eye Care Hospital, 82-b Kitchlu Nagar, Ludhiana, Punjab
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ijo.IJO_3163_21
|
|
|
A 64-year-old gentleman presented with decreased vision, raised intraocular pressure, and anterior chamber reaction of 1+ with grade 3 vitreous exudates on day 5 after intravitreal Ozurdex® implant. Microbiological culture showed no bacterial or fungal growth. On suspicion of viral endophthalmitis, the patient was started on topical prednisolone, moxifloxacin, atropine, dorzolamide, and timolol eye drops and oral valacyclovir 1 g twice a day for 10 days. On day 9, a vesicular eruption was noted on the left forehead, confirming the diagnosis of herpes zoster-related shingles infection. Complete resolution of inflammation was noted on day 30. This is the first case report highlighting the occurrence of ocular zoster infection after an intravitreal Ozurdex® implant.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
